Overview
- ATAGI says falsified batches of the Abhayrab rabies vaccine have circulated in India since November 1, 2023, raising concerns that recipients may not be protected.
- People who received Abhayrab in India from that date should be managed as potentially affected and offered replacement doses with Australian-registered vaccines.
- Guidance cited by Australian media includes using Rabipur or Verorab for replacement dosing and checking rabies antibody levels to confirm an adequate response.
- Authorities note Abhayrab is not supplied in Australia and confirmation of genuine doses is difficult, so travellers unsure of the brand or lacking documentation should seek prompt review.
- Indian Immunologicals Limited reported the counterfeit batches, as WHO figures highlight India’s heavy rabies burden, reinforcing advice on pre-travel consultation, animal avoidance, wound washing, and careful record-keeping.